Selected article for: "partial thromboplastin time and thromboplastin time"
Author: Hongzhou Lu; Jingwen Ai; Yinzhong Shen; Yang Li; Tao Li; Xian Zhou; Haocheng Zhang; Qiran Zhang; Yun Ling; Sheng Wang; Hongping Qu; Yuan Gao; Yingchuan Li; Kanglong Yu; Duming Zhu; Hecheng Zhu; Rui Tian; Mei Zeng; Qiang Li; Yuanlin Song; Xiangyang Li; Jinfu Xu; Jie Xu; Enqiang Mao; Bijie Hu; Xin Li; Lei Zhu; Wenhong Zhang
Title: A descriptive study of the impact of diseases control and prevention on the epidemics dynamics and clinical features of SARS-CoV-2 outbreak in Shanghai, lessons learned for metropolis epidemics prevention
  • Document date: 2020_2_23
    • ID: dbzrd23n_36
    Snippet: The copyright holder for this preprint (which was not peer-reviewed) is . https://doi.org /10.1101 /10. /2020 aminotransferase, albumin, serum creatine, and eGFR), coagulation function (activated 213 partial thromboplastin time, fibrin degradation products , and D-dimer), and infection-214 related biomarkers (CRP and procalcitonin). The counts of CD4+ and CD8+ cell of severe 215 or critically ill patients were 205/μl and 135/μl, significantly l.....
    Document: The copyright holder for this preprint (which was not peer-reviewed) is . https://doi.org /10.1101 /10. /2020 aminotransferase, albumin, serum creatine, and eGFR), coagulation function (activated 213 partial thromboplastin time, fibrin degradation products , and D-dimer), and infection-214 related biomarkers (CRP and procalcitonin). The counts of CD4+ and CD8+ cell of severe 215 or critically ill patients were 205/μl and 135/μl, significantly lower than those of the mild or 216 moderate patients (Figure 4) . 217

    Search related documents:
    Co phrase search for related documents
    • coagulation function and fibrin degradation product: 1
    • coagulation function and partial thromboplastin time: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • coagulation function and procalcitonin crp: 1, 2, 3, 4, 5, 6, 7, 8
    • coagulation function and serum creatine: 1, 2, 3, 4, 5
    • coagulation function and thromboplastin time: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • degradation product and fibrin degradation product: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • degradation product and partial thromboplastin time: 1, 2
    • degradation product and procalcitonin crp: 1
    • degradation product and thromboplastin time: 1, 2
    • fibrin degradation product and partial thromboplastin time: 1, 2
    • fibrin degradation product and procalcitonin crp: 1
    • fibrin degradation product and thromboplastin time: 1, 2
    • moderate patient and partial thromboplastin time: 1
    • moderate patient and procalcitonin crp: 1, 2
    • moderate patient and thromboplastin time: 1
    • partial thromboplastin time and procalcitonin crp: 1, 2
    • partial thromboplastin time and serum creatine: 1, 2
    • partial thromboplastin time and thromboplastin time: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • procalcitonin crp and serum creatine: 1